Study Enrollment

Your details will not be published or shared.

Clinical Trial

Immunogenicity, Compliance, Knowledge and Attitudes in Postpartum Women during a Two Dose 9-valent HPV Vaccination Series

This study will look at how well a vaccine for the HPV vaccine works on the immune system of women age 16 to 45 who are postpartum. Women will receive the vaccine within one week of delivery of their baby. The study will compare the results to women in the same age range who are not postpartum. Participation will last approximately one year and involve 4 visits to the clinic.

Eligibility Criteria

  • Eligibility Criteria: Women age 16 to 45 at time of enrollment Postpartum (Day 1 vaccination to occur within 1 week of delivery) Judged to be in good health based on medical history and physical examination Able to understand the study procedures, alternative treatments, and risks involved with the study

Contact Information

    Angela Goebel

    (706) 721-8944